268 results
Page 5 of 14
8-K
EX-99.1
h168kx r4
3 Dec 19
Health Canada Grants Priority Review Status for Heron Therapeutics’ New Drug Submission for HTX-011 for Management of Postoperative Pain
7:41am
8-K
EX-99.1
o8kpu7g l8ob
12 Nov 19
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
h0ygmtbmgibrqtj68
28 Oct 19
Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain
8:41am
8-K
EX-99.1
w4t4u7qej
22 Oct 19
Other Events
8:42am
424B2
xm0gcgw6ekz5rxi8
7 Oct 19
Prospectus for primary offering
4:28pm
424B5
qgsdq6nkx4o0s
3 Oct 19
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.1
fmrm28twqczlz8l6mk
2 Oct 19
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
7:57am
8-K
EX-99.2
qdbal 9t2dknf94
2 Oct 19
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
7:57am
8-K
EX-99.1
943cadh5b o4l
1 Oct 19
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Management of Postoperative Pain
8:42am
8-K
EX-99.1
d13hye mwpyg4bg
20 Aug 19
Heron Therapeutics Announces Publication of Results from EPOCH 2, a Phase 3 Study of HTX-011 in Patients Undergoing Hernia Repair Surgery
8:35am
8-K
EX-99.1
iqjl38pih
5 Aug 19
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
wjhc5h
21 May 19
Heron Therapeutics Announces Publication of Results from Phase 3 EPOCH 1 Study ofHTX-011 in Patients Undergoing Bunionectomy
9:15am
8-K
EX-99.1
y1tzv9l4ldrq
14 May 19
Heron Therapeutics Presents New Results from Real-world Study Showing
8:35am
8-K
EX-99.1
e08n 54z09
9 May 19
Results of Operations and Financial Condition
8:35am
8-K
EX-99.1
uo75emcry3js3r5bvzn7
1 May 19
Heron Therapeutics Receives Complete Response Letter FORHTX-011 for the Management of Postoperative Pain
8:06am
8-K
EX-99.1
0rris4f0qhv4cpzw1gdj
26 Feb 19
Heron Announces FDA Approval of
4:10pm